Company logo

WST - West Pharmaceutical Services, Inc.

NYSE -> Healthcare -> Medical Instruments & Supplies
Exton, United States

WST price evolution
WST
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $688 $576.2 $483.7 $615.5
Short term investments
Net receivables $476.4 $480.5 $465.7 $385.3
Inventory $353.8 $345.2 $310.2 $321.3
Total current assets $1598.3 $1477 $1327 $1373.7
Long term investments $215.7 $211.7 $211.9 $214.7
Property, plant & equipment $1065 $1035.9 $995.3 $1011.5
Goodwill & intangible assets $135 $137.8 $138.2 $141.6
Total noncurrent assets $1544.3 $1456.5 $1412.7 $1420.1
Total investments $215.7 $211.7 $211.9 $214.7
Total assets $3142.6 $2933.5 $2739.7 $2793.8
Current liabilities
Accounts payable $207.7 $205.1 $204.3 $213.1
Deferred revenue
Short long term debt $52.3 $11.6 $11.7 $12.4
Total current liabilities $558.6 $472.6 $482.8 $503.4
Long term debt $263.3 $307.8 $309.7 $313.3
Total noncurrent liabilities $381.7 $428.3 $427.9 $435.9
Total debt $315.6 $319.4 $321.4 $325.7
Total liabilities $940.3 $900.9 $910.7 $939.3
Shareholders' equity
Retained earnings $2335.8 $2160.2 $1985.4 $1846.7
Other shareholder equity -$155.7 -$133.2 -$140.2 -$110.6
Total shareholder equity $2202.3 $2032.6 $1829 $1854.5
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $615.5 $439.1 $337.4 $235.9
Short term investments
Net receivables $385.3 $319.3 $288.2 $253.2
Inventory $321.3 $235.7 $214.5 $215.2
Total current assets $1373.7 $1058.7 $894.4 $743.5
Long term investments $214.7 $192.7 $91.2 $85.8
Property, plant & equipment $1011.5 $909.4 $822 $855
Goodwill & intangible assets $141.6 $137.6 $126.1 $129.4
Total noncurrent assets $1420.1 $1282.7 $1084.5 $1119.3
Total investments $214.7 $192.7 $91.2 $85.8
Total assets $2793.8 $2341.4 $1978.9 $1862.8
Current liabilities
Accounts payable $213.1 $156.8 $130.4 $138.1
Deferred revenue
Short long term debt $12.4 $11.9 $0.1
Total current liabilities $503.4 $341.6 $283.7 $279.5
Long term debt $313.3 $317.4 $196 $197
Total noncurrent liabilities $435.9 $426.6 $298.9 $303.4
Total debt $325.7 $329.3 $196.1 $197
Total liabilities $939.3 $768.2 $582.6 $582.9
Shareholders' equity
Retained earnings $1846.7 $1549.4 $1353.4 $1178.2
Other shareholder equity -$110.6 -$149.6 -$154.2 -$117.3
Total shareholder equity $1854.5 $1573.2 $1396.3 $1279.9
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue $706.5 $723.6 $670.7 $580.2
Cost of revenue $418.3 $408.5 $398.8 $369.1
Gross Profit $288.2 $315.1 $271.9 $211.1
Operating activities
Research & development $13.1 $13.8 $12.2 $12.9
Selling, general & administrative $91.9 $92.7 $80.2 $76.3
Total operating expenses $106.8 $103.8 $96.3 $95
Operating income $181.4 $211.3 $175.6 $116.1
Income from continuing operations
EBIT $189.4 $221.5 $181.8 $120.9
Income tax expense $12 $32.3 $28.7 $20.4
Interest expense $1.8 $1.9 $1.9 $2.1
Net income
Net income $175.6 $187.3 $151.2 $98.4
Income (for common shares) $175.6 $187.3 $151.2 $98.4
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue $2146.9 $1839.9 $1717.4 $1599.1
Cost of revenue $1379.1 $1234.2 $1172 $1086.5
Gross Profit $767.8 $605.7 $545.4 $512.6
Operating activities
Research & development $46.9 $38.9 $40.3 $39.1
Selling, general & administrative $302 $272.7 $262.9 $242.6
Total operating expenses $360.9 $311.6 $305.1 $283.7
Operating income $406.9 $294.1 $240.3 $228.9
Income from continuing operations
EBIT $426.9 $309.2 $256.7 $239.4
Income tax expense $72.5 $59 $41.4 $80.9
Interest expense $8.2 $8.5 $8.4 $7.8
Net income
Net income $346.2 $241.7 $206.9 $150.7
Income (for common shares) $346.2 $241.7 $206.9 $150.7
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income $175.6 $187.3 $151.2 $98.4
Operating activities
Depreciation $30 $28.8 $29.1 $28.5
Business acquisitions & disposals
Stock-based compensation $11.3 $10.3 $5.9 $6.4
Total cash flows from operations $190.1 $144.4 $88.7 $148.7
Investing activities
Capital expenditures -$65.3 -$56.9 -$54.7 -$57.7
Investments
Total cash flows from investing -$65.3 -$55.9 -$54.5 -$57.6
Financing activities
Dividends paid -$12.6 -$12.6 -$12.6 -$12.6
Sale and purchase of stock $5 $11.3 -$145 $2.7
Net borrowings -$0.5 -$0.6 -$0.6
Total cash flows from financing -$5.8 $0.3 -$156.4 -$8.7
Effect of exchange rate -$7.2 $3.7 -$9.6 $13.7
Change in cash and equivalents $111.8 $92.5 -$131.8 $96.1
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income $346.2 $241.7 $206.9 $150.7
Operating activities
Depreciation $109.1 $103.4 $104.4 $96.7
Business acquisitions & disposals -$104 -$6
Stock-based compensation $34 $24.4 $15.1 $16.1
Total cash flows from operations $472.5 $367.2 $288.6 $263.3
Investing activities
Capital expenditures -$174.4 -$126.4 -$104.7 -$130.8
Investments
Total cash flows from investing -$179.5 -$228 -$100.8 -$133.6
Financing activities
Dividends paid -$48.1 -$45.1 -$42.1 -$39.1
Sale and purchase of stock -$93.1 -$58 -$43.4 -$38.7
Net borrowings -$2.3 $60.9 -$0.1 -$34.9
Total cash flows from financing -$137.1 -$36.8 -$80.7 -$109
Effect of exchange rate $20.5 -$0.7 -$5.6 $12.2
Change in cash and equivalents $176.4 $101.7 $101.5 $32.9
Fundamentals
Market cap $32.16B
Enterprise value $31.79B
Shares outstanding 74.08M
Revenue $2.68B
EBITDA $830.00M
EBIT $713.60M
Net Income $612.50M
Revenue Q/Q 28.92%
Revenue Y/Y 31.60%
P/E ratio 52.51
EV/Sales 11.86
EV/EBITDA 38.30
EV/EBIT 44.55
P/S ratio 12.00
P/B ratio 13.64
Book/Share 31.83
Cash/Share 9.29
EPS $8.27
ROA 21.10%
ROE 30.94%
Debt/Equity 0.51
Net debt/EBITDA 0.30
Current ratio 2.86
Quick ratio 2.23